Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 749 posts found.

lynparza

AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival

February 17, 2021
Research and Development AstraZeneca, Cancer, MSD

The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …

News
who_flag

WHO approves two versions of AstraZeneca’s COVID-19 vaccine

February 16, 2021
Manufacturing and Production AstraZeneca, COVID-19, WHO

The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …

News
enhertu

Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu approved in UK

February 16, 2021
Manufacturing and Production AstraZeneca, Cancer, Daiichi Sankyo

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has been granted conditional authorisation in the UK as a monotherapy for the …

News
astrazeneca_sign_sky

AstraZeneca’s COVID-19 vaccine to be trialled in children

February 15, 2021
Sales and Marketing AstraZeneca, COVID-19

The Oxford-AstraZeneca COVID-19 vaccine is to be tested on children in the UK in a new trial commencing this month. …

News
who_flag

AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances

February 12, 2021
Medical Communications AstraZeneca, COVID-19

Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated …

News
who_flag

WHO panel recommends AstraZeneca COVID-19 vaccine for over-65s

February 11, 2021
AstraZeneca, COVID-19, WHO

Scientists advising the WHO have recommended the use of the Oxford-AstraZeneca COVID-19 vaccine in all adults, including those aged over …

News
astrazeneca_sign_sky

South Korea approves AstraZeneca COVID-19 vaccine for use

February 10, 2021
Research and Development AstraZeneca, COVID-19

South Korea is to grant first approval for the Oxford University-AstraZeneca vaccine later today, with the rollout expected to start …

News
astrazeneca_building_white

South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns

February 8, 2021
Sales and Marketing AstraZeneca, COVID-19

AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …

News
astrazeneca-sign

New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October

February 5, 2021
Medical Communications AstraZeneca, COVID-19

Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …

News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi misses target in Phase III head and neck cancer trial

February 5, 2021
Medical Communications AstraZeneca, Cancer

AstraZeneca’s Imfinzi (durvalumab) has failed to improve overall survival (OS) for patients with recurrent or metastatic head and neck cancer …

News
astrazeneca-sign

China approves AstraZeneca’s heart failure drug Forxiga

February 4, 2021
AstraZeneca, Forxiga

AstraZeneca’s Forxiga (dapagliflozin) has been approved for use in China to reduce the risk of death and hospitalisation from heart …

News
astrazeneca_sign_sky

Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says

February 3, 2021
Research and Development AstraZeneca, COVID-19

A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …

News
astrazeneca-sign

AstraZeneca COVID-19 vaccine not for over 65s, German health body says

January 29, 2021
Medical Communications AstraZeneca, COVID-19

Germany’s main public health body has recommended that AstraZeneca’s COVID-19 vaccine is only administered to those aged between 18 and …

News
astrazeneca_building_white

AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy

January 26, 2021
Manufacturing and Production AstraZeneca, COVID-19

AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …

News
astrazeneca_sign_sky

EU approves breast cancer drug Enhertu

January 20, 2021
Research and Development AstraZeneca, Daiichi Sankyo

The EU has granted AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) conditional approval as a monotherapy for the treatment of …

News

Latest content

FDA grants marketing authorisation to DNA test for predisposition to certain cancers

October 2, 2023

Biogen’s biosimilar Tofidence approved by FDA

October 2, 2023

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023